Search results for

In Indiana, Republican primary voters on Tuesday decide whether to give GOP Sen. Richard Lugar the chance at a seventh term. Polls show him in trouble, with his Tea Party-backed opponent in the lead. But for some, Lugar's perceived strength in the general election will influence their vote.

Falcon Lake, on the U.S.-Mexico border, has been named the best bass fishing lake in the country. But a Mexican drug cartel also uses the lake to smuggle drugs. While that hasn't kept the anglers away, it does mean fishing there carries an element of risk.

The likely Democratic presidential pack is embracing ambitious economic policies, like Medicare for all and a $15 minimum wage. Those policies could drive the big debates during the 2020 primaries.

The Supreme Court justice revealed on Friday that she had begun a course of chemotherapy on May 19. In a statement, she said she is still able to do her job "full steam."

It is difficult to find work if you've been incarcerated. Outside Seattle, one women's prison is trying to give inmates a better chance by training some of them for nontraditional jobs.

Federal officials say executives from the now-defunct Peanut Corp. of America knowingly distributed peanut products that were contaminated with salmonella. The charges stem from a 2009 salmonella outbreak that sickened more than 700 people.

The number of multiracial churches is growing in the United States, but the leaders of color who work in them still see attitudes of white supremacy.

A growing number of those seeking help from mortgage counselors are high-income owners of million-dollar homes in wealthy communities like Laguna Beach, Calif., and Westchester County, N.Y. But large home loans can be more difficult to modify than more modest ones.

Weibo, China's equivalent of Twitter, is changing the way the Chinese communicate and has become a major source of news. Its more than 300 million users are, among other things, using it to criticize government policies, stop official injustice and help ordinary people — but only up to a point.

A new Alzheimer's drug isn't reaching many patients. Doctors say reasons include its high cost, and lingering questions about its effectiveness.